Yıl: 2022 Cilt: 28 Sayı: 2 Sayfa Aralığı: 372 - 380 Metin Dili: Türkçe DOI: 10.5336/dentalsci.2021-83767 İndeks Tarihi: 15-06-2022

MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi

Öz:
MTA Fillapex ve AH Plus kanal dolum patlarının, insan hücrelerindeki genotoksik ve sitotoksik etkileri ve insan kan lenfositlerindeki potansiyel genotoksik etkileri ve genotoksisite mekanizmasının işleyişi hakkında yeterli bilgi bulunmamaktadır. Bu sebepler göz önünde bulundurularak, çalışmamızda mevcut materyallerin genotoksisite ve sitotoksisite etkinliği araştırmak amacıyla Sitokinez-Bloke Mikronükleus Sitom yönteminin kullanımı ile ulaşılması hedeflenen etkilerin araştırılması amaçlanmıştır. Gereç ve Yöntemler: Yaşları 20- 35 arasında değişen sağlıklı, herhangi bir rutin ilaç kullanımı ve bağımlılığı bulunmayan 10 bireyden 10 mL kan alındı. Bu örneklerle elde edilen lenfosit kültürlerine değişik konsantrasyonlarda MTA Fillapex ve AH Plus kanal dolgu patları eklendi. Bulunan mikronükleuslu binükleer hücreler, gözlenen metafaz sayıları, nükleoplazmik köprülü [nucleoplasmic bridged (NPB)] ve nükleer tomurcuklu hücreler sayıldı. Preparatlarda 1.000 adet hücre sayıldıktan sonra apoptotik ve nekrotik hücrelerin mevcudiyeti de kayıt altına alındı. Bulgular: Veriler, parametrik olmayan Wilcoxon T-testi ile değerlendirildi. MTA Fillapex patı doz artışıyla beraber toksisitesinde de artış gözlenmiştir. Fakat NPB hücrelerin parametresi hariç tüm parametrelerde, pozitif kontrole göre anlamlı seviyede daha az seviyelerde toksisite saptanmıştır. NPB hücrelere ait bulgular incelendiğinde, MTA Fillapex grubu ile pozitif kontrol arasında istatistiksel açıdan anlamlı bir farka rastlanmamıştır. AH Plus polimerizasyon süresi boyunca toksisite göstermiştir. Sonuç: MTA Fillapex patı, insan kan hücreleri üzerinde AH Plus macununa göre daha az sitotoksik ve genotoksik etki göstermiştir.
Anahtar Kelime:

MTA Fillapex In Vitro Genotoxicity Assessment: A Systematic Review

Öz:
There is a few information about the genotoxic and cytotoxic effects of MTA Fillapex and AH Plus canal filling pastes in human pulp and pulp blood cells. And even that we know the there are some cytotoxic effects on the blood cells there is not enough data about the mechanism of these effects. Considering these reasons, in our study, it was aimed to investigate genotoxic and cytotoxic efficiency of the available materials by using the Cytokinesis-Blocked Micronucleus Cytome method. Material and Methods: 10 mL blood was obtained from ten healthy persons aged 20-35 years who did not use pharmaceuticals or were addicted to them on a regular basis. To the lymphocyte cultures derived from these samples, various quantities of MTA Fillapex and AH Plus channel fillers were applied. Micronucleus binuclear cells found, observed metaphase numbers, nucleoplasmic bridged (NPB) and nuclear bud cells were counted. After counting 1,000 cells in the samples, the presence of apoptotic and necrotic cells was also recorded for the statistical data. Results: Data were evaluated with nonparametric the Wilcoxon T-test. When the findings were evaluated, it was observed that the toxicity of MTA Fillapex increased with the dose. However, in all parameters except the NPB cells parameter, significantly less toxicity was detected compared to the positive control. After we observe data about NPB cells we found that there is no statistically significant difference between the MTA Fillapex group and positive control group also AH Plus study group showed toxicity during the polymerization period. Conclusion: MTA Fillapex paste showed less cytotoxic and genotoxic effect than AH Plus paste on the human blood cells.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Jafari F, Jafari S, Etesamnia P. Genotoxicity, bioactivity and clinical properties of calcium silicate based sealers: a literature review. Iran Endod J. 2017;12(4):407-13. [PubMed] [PMC]
  • 2. Al-Haddad A, Abu Kasim NH, Che Ab Aziz zA. Interfacial adaptation and thickness of bioceramic-based root canal sealers. Dent Mater J. 2015;34(4):516-21. [Crossref] [PubMed]
  • 3. Al-Haddad A, Che Ab Aziz zA. Bioceramic-based root canal sealers: a review. Int J Biomater. 2016;2016:9753210. [Crossref] [PubMed] [PMC]
  • 4. Leonardo MR, Bezerra da Silva LA, Filho MT, Santana da Silva R. Release of formaldehyde by 4 endodontic sealers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88(2):221-5. [Crossref] [PubMed]
  • 5. Torabinejad M, Watson TF, Pitt Ford TR. Sealing ability of a mineral trioxide aggregate when used as a root end filling material. J Endod. 1993;19(12):591-5. [Crossref] [PubMed]
  • 6. Roberts HW, Toth JM, Berzins DW, Charlton DG. Mineral trioxide aggregate material use in endodontic treatment: a review of the literature. Dent Mater. 2008;24(2):149-64. [Crossref] [PubMed]
  • 7. Parirokh M, Torabinejad M. Mineral trioxide aggregate: a comprehensive literature review--Part I: chemical, physical, and antibacterial properties. J Endod. 2010;36(1):16-27. [Crossref] [PubMed]
  • 8. Holland R, de Souza V, Nery MJ, Otoboni Filho JA, Bernabé PF, Dezan Júnior E. Reaction of rat connective tissue to implanted dentin tubes filled with mineral trioxide aggregate or calcium hydroxide. J Endod. 1999;25(3):161-6. [Crossref] [PubMed]
  • 9. Hauman CH, Love RM. Biocompatibility of dental materials used in contemporary endodontic therapy: a review. Part 1. Intracanal drugs and substances. Int Endod J. 2003; 36(2):75-85. [Crossref] [PubMed]
  • 10. Jaberiansari z, Naderi S, Tabatabaei FS. Cytotoxic effects of various mineral trioxide aggregate formulations, calcium-enriched mix ture and a new cement on human pulp stem cells. Iran Endod J. 2014;9(4):271- 6. [PubMed] [PMC]
  • 11. Saygili G, Saygili S, Tuglu I, Davut Capar I. In vitro cytotoxicity of GuttaFlow Bioseal, GuttaFlow 2, AH-Plus and MTA Fillapex. Iran Endod J. 2017;12(3):354-9. [PubMed] [PMC]
  • 12. Braz MG, Camargo EA, Salvadori DM, Marques ME, Ribeiro DA. Evaluation of genetic damage in human peripheral lymphocytes exposed to mineral trioxide aggregate and Portland cements. J Oral Rehabil. 2006;33(3): 234-9. [Crossref] [PubMed]
  • 13. Accorinte Mde L, Holland R, Reis A, Bortoluzzi MC, Murata SS, Dezan E Jr, et al. Evaluation of mineral trioxide aggregate and calcium hydroxide cement as pulp-capping agents in human teeth. J Endod. 2008;34(1):1-6. [Crossref] [PubMed]
  • 14. Mantellini MG, Botero TM, Yaman P, Dennison JB, Hanks CT, Nör JE. Adhesive resin induces apoptosis and cell-cycle arrest of pulp cells. J Dent Res. 2003;82(8):592-6. [Crossref] [PubMed]
  • 15. zeferino EG, Bueno CE, Oyama LM, Ribeiro DA. Ex vivo assessment of genotoxicity and cytotoxicity in murine fibroblasts exposed to white MTA or white Portland cement with 15% bismuth oxide. Int Endod J. 2010;43(10):843-8. [Crossref] [PubMed]
  • 16. Ding SJ, Kao CT, Chen CL, Shie MY, Huang TH. Evaluation of human osteosarcoma cell line genotoxicity effects of mineral trixoide aggregate and calcium silicate cements. J Endod. 2010;36(7):1158-62. [Crossref] [PubMed]
  • 17. Ribeiro DA, Sugui MM, Matsumoto MA, Duarte MA, Marques ME, Salvadori DM. Genotoxicity and cytotoxicity of mineral trioxide aggregate and regular and white Portland cements on Chinese hamster ovary (CHO) cells in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(2):258-61. [Crossref] [PubMed]
  • 18. Widel M, Kolosza z, Jedruś S, Lukaszczyk B, Raczek-zwierzycka K, Swierniak A. Micronucleus assay in vivo provides significant prognostic information in human cervical carci noma; the updated analysis. Int J Radiat Biol. 2001;77(5):631-6. [Crossref] [PubMed]
  • 19. Fenech M, Morley A. Solutions to the kinetic problem in the micronucleus assay. Cytobios. 1985;43(172-173):233-46. [PubMed]
  • 20. Olsson B, Sliwkowski A, Langeland K. Intraosseous implantation for biological evaluation of endodontic materials. J Endod. 1981; 7(6):253-65. [Crossref] [PubMed]
  • 21. Stanley HR. Local and systemic responses to dental composites and glass ionomers. Adv Dent Res. 1992;6:55-64. [Crossref] [PubMed]
  • 22. Torabinejad M, Hong CU, Pitt Ford TR, Kettering JD. Cytotoxicity of four root end filling materials. J Endod. 1995;21(10):489-92. [Crossref] [PubMed]
  • 23. Bin CV, Valera MC, Camargo SE, Rabelo SB, Silva GO, Balducci I, et al. Cytotoxicity and genotoxicity of root canal sealers based on mineral trioxide aggregate. J Endod. 2012;38(4):495-500. [Crossref] [PubMed]
  • 24. Camargo SE, Camargo CH, Hiller KA, Rode SM, Schweikl H, Schmalz G. Cytotoxicity and genotoxicity of pulp capping materials in two cell lines. Int Endod J. 2009;42(3):227-37. [Crossref] [PubMed]
  • 25. Chen CL, Kao CT, Ding SJ, Shie MY, Huang TH. Expression of the inflammatory marker cyclooxygenase-2 in dental pulp cells cultured with mineral trioxide aggregate or calcium silicate cements. J Endod. 2010;36(3):465-8. [Crossref] [PubMed]
  • 26. da Silva GN, Braz MG, de Camargo EA, Salvadori DM, Ribeiro DA. Genotoxicity in primary human peripheral lymphocytes after exposure to regular and white mineral trioxide aggregate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(5):e50-4. [Crossref] [PubMed]
  • 27. Menezes R, Bramante CM, Letra A, Carvalho VG, Garcia RB. Histologic evaluation of pulpotomies in dog using two types of mineral trioxide aggregate and regular and white Portland cements as wound dressings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98(3):376-9. [Crossref] [PubMed]
  • 28. Jafari F, Aghazadeh M, Jafari S, Khaki F, Kabiri F. In vitro cytotoxicity comparison of MTA Fillapex, AH-26 and apatite root canal sealer at different setting times. Iran Endod J. 2017;12(2):162-7. [PubMed] [PMC]
  • 29. Collado-González M, Tomás-Catalá CJ, O-ate-Sánchez RE, Moraleda JM, Rodríguez-Lozano FJ. Cytotoxicity of GuttaFlow Bioseal, GuttaFlow2, MTA Fillapex, and AH Plus on human periodontal ligament stem cells. J Endod. 2017;43(5):816-22. [Crossref] [PubMed]
  • 30. Spahl W, Budzikiewicz H. Qualitative analysis of dental resin composites by gas and liquid chromatography/mass spectrometry. Fresen J Anal Chem. 1994;350:684-91. [Crossref]
  • 31. Gulati N, Chandra S, Aggarwal PK, Jaiswal JN, Singh M. Cytotoxicity of eugenol in sealer containing zinc-oxide. Endod Dent Traumatol. 1991;7(4):181-5. [Crossref] [PubMed]
  • 32. Kolokouris I, Kotsaki-Kovatsi VP, Economides N, Poulopoulos A, Rozos G, Vlemmas I. Influence of zinc oxide and eugenol sealer on concentration of zinc, calcium and copper in rat tissues. Endod Dent Traumatol. 1998;14(5): 210-3. [Crossref] [PubMed]
  • 33. Nencka D, Walia HD, Austin BP. Histologic evaluation of the biocompatibility of Diaket. J Dent Res. 1995;74:101.
  • 34. Spångberg L. Biological effects of root canal filling materials. 4. Effect in vitro of solubilised root canal filling materials on HeLa cells. Odontol Revy. 1969;20(3):289-99. [PubMed]
APA ARSLAN S, üstün y, TAŞÇIOĞLU N, durukan s, Sagsen B, Onal M, Dundar M (2022). MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi. , 372 - 380. 10.5336/dentalsci.2021-83767
Chicago ARSLAN SOLEY,üstün yakup,TAŞÇIOĞLU Nazife,durukan sebahat melike,Sagsen Burak,Onal Muge Gulcihan,Dundar Munis MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi. (2022): 372 - 380. 10.5336/dentalsci.2021-83767
MLA ARSLAN SOLEY,üstün yakup,TAŞÇIOĞLU Nazife,durukan sebahat melike,Sagsen Burak,Onal Muge Gulcihan,Dundar Munis MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi. , 2022, ss.372 - 380. 10.5336/dentalsci.2021-83767
AMA ARSLAN S,üstün y,TAŞÇIOĞLU N,durukan s,Sagsen B,Onal M,Dundar M MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi. . 2022; 372 - 380. 10.5336/dentalsci.2021-83767
Vancouver ARSLAN S,üstün y,TAŞÇIOĞLU N,durukan s,Sagsen B,Onal M,Dundar M MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi. . 2022; 372 - 380. 10.5336/dentalsci.2021-83767
IEEE ARSLAN S,üstün y,TAŞÇIOĞLU N,durukan s,Sagsen B,Onal M,Dundar M "MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi." , ss.372 - 380, 2022. 10.5336/dentalsci.2021-83767
ISNAD ARSLAN, SOLEY vd. "MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi". (2022), 372-380. https://doi.org/10.5336/dentalsci.2021-83767
APA ARSLAN S, üstün y, TAŞÇIOĞLU N, durukan s, Sagsen B, Onal M, Dundar M (2022). MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi. Türkiye Klinikleri Diş Hekimliği Bilimleri Dergisi, 28(2), 372 - 380. 10.5336/dentalsci.2021-83767
Chicago ARSLAN SOLEY,üstün yakup,TAŞÇIOĞLU Nazife,durukan sebahat melike,Sagsen Burak,Onal Muge Gulcihan,Dundar Munis MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi. Türkiye Klinikleri Diş Hekimliği Bilimleri Dergisi 28, no.2 (2022): 372 - 380. 10.5336/dentalsci.2021-83767
MLA ARSLAN SOLEY,üstün yakup,TAŞÇIOĞLU Nazife,durukan sebahat melike,Sagsen Burak,Onal Muge Gulcihan,Dundar Munis MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi. Türkiye Klinikleri Diş Hekimliği Bilimleri Dergisi, vol.28, no.2, 2022, ss.372 - 380. 10.5336/dentalsci.2021-83767
AMA ARSLAN S,üstün y,TAŞÇIOĞLU N,durukan s,Sagsen B,Onal M,Dundar M MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi. Türkiye Klinikleri Diş Hekimliği Bilimleri Dergisi. 2022; 28(2): 372 - 380. 10.5336/dentalsci.2021-83767
Vancouver ARSLAN S,üstün y,TAŞÇIOĞLU N,durukan s,Sagsen B,Onal M,Dundar M MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi. Türkiye Klinikleri Diş Hekimliği Bilimleri Dergisi. 2022; 28(2): 372 - 380. 10.5336/dentalsci.2021-83767
IEEE ARSLAN S,üstün y,TAŞÇIOĞLU N,durukan s,Sagsen B,Onal M,Dundar M "MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi." Türkiye Klinikleri Diş Hekimliği Bilimleri Dergisi, 28, ss.372 - 380, 2022. 10.5336/dentalsci.2021-83767
ISNAD ARSLAN, SOLEY vd. "MTA Fillapex’in İn Vitro Genotoksisitesinin Değerlendirilmesinin Sistematik İncelemesi". Türkiye Klinikleri Diş Hekimliği Bilimleri Dergisi 28/2 (2022), 372-380. https://doi.org/10.5336/dentalsci.2021-83767